Boston Biotechs

Simplifying #ClinicalResearch. #ClinicalStrategy and #CostEffective #TrialDesign specialists. #RareDisease and #OrphanIndication experts.

[Boston Biotechs @BostonBioTechs]

Why do orphan drug launches require specialized strategic planning? https://t.co/z34VNVUPMV

[Boston Biotechs @BostonBioTechs]

BBCR and its consultants are dedicated to advancing innovative and repurposed treatments for orphan diseases, an area where impact is high, but the path is complex. https://t.co/TQAzhIEMzt

[Boston Biotechs @BostonBioTechs]

BBCR’s mission is to support domestic and international pharma, biotech, and device companies by nurturing their products’ strengths, while improving efficiency and safety. We specialize in strategy and provide early clinical research services to enable… https://t.co/5XZvqn4wYZ

[Boston Biotechs @BostonBioTechs]

BBCR brings deep expertise in early-stage development, including Phase 1 and Phase 2 process and strategy, spanning pre-clinical work through pre-IND. Our early drug development capabilities encompass clinical strategy and planning, including the… https://t.co/ymFKvdJe5S

[Boston Biotechs @BostonBioTechs]

BBCR partners with clients to identify, develop, and advance a product’s unique strengths from early concept through to market. Our consultancy is grounded in deep expertise across cell, biologic, and gene therapies, with a particular focus on rare… https://t.co/4vjNuAL9uf

[Boston Biotechs @BostonBioTechs]

BBCR’s team of experts help clients match treatments to rare genetic conditions and unsolved diseases, then work collaboratively with a product developer on the best plan to market. To learn more, visit https://t.co/9MpR7llV4C. https://t.co/0a2fYgVAPs

[Boston Biotechs @BostonBioTechs]

Drug repurposing accelerates the path from discovery to the clinic, offering particular promise for rare, neglected, oncologic, and neurodegenerative diseases. Learn how we can help at https://t.co/9MpR7llV4C https://t.co/myocgZ3f3l

[Boston Biotechs @BostonBioTechs]

Is Your Drug Development Strategy Built for Tomorrow’s Success? https://t.co/fyfYogpbcy

[Boston Biotechs @BostonBioTechs]

BBCR assists companies with the identification and adoption of biomarkers, now a routine part of drug development, and especially valuable in rare disease and precision medicine product development. Reach out to us to learn how we can assist with your… https://t.co/MnoIl2CAQ8

[Boston Biotechs @BostonBioTechs]

Partnering with BBCR Consulting means gaining the support of a specialized team committed to making the clinical trial process more efficient. https://t.co/h4PbO9pT1K

[Boston Biotechs @BostonBioTechs]

Who is BBCR and how do we help pharmaceutical innovators in the specialized rare diseases and orphan drug industries? We invite you to learn more at https://t.co/9MpR7llV4C. https://t.co/J86lsDBtJ6

[Boston Biotechs @BostonBioTechs]

Accelerate Drug Development with Biomarker Strategy in Orphan Diseases and Precision Medicine https://t.co/cy5ZthCqHY

[Boston Biotechs @BostonBioTechs]

At BBCR, our team of seasoned experts is dedicated to helping clients navigate the intricate landscape of rare genetic conditions and unsolved diseases. We work hand in hand with product developers to create the most effective strategies for bringing… https://t.co/lpBmzljPpU

[Boston Biotechs @BostonBioTechs]

Our experienced CRO Management and Drug development team identify study remediation strategies and provide a resource for any Study Rescue. We invite you to reach out to learn more – visit https://t.co/9MpR7llV4C. https://t.co/cIlQzkcgZ6

[Boston Biotechs @BostonBioTechs]

A pioneering figure in the area of rare diseases and orphan drug early-stage clinical research and regulatory strategies, Dr. Candida Fratazzi has an impressive 25-year track record in this specialized field. https://t.co/H4MUwzLLi7

[Boston Biotechs @BostonBioTechs]

BBCR is committed to cultivating and enhancing a product’s unique strengths at every stage, from initial conception to successful market launch. With deep expertise in cell therapy, biologics, and gene therapy—particularly in the realm of rare… https://t.co/UCKJd78iUQ

[Boston Biotechs @BostonBioTechs]

BBCR embraces innovative strategic consulting for highly effective clinical development planning and regulatory strategy. Reach out today to learn more about how we can help advance your project. https://t.co/3vHqTynyOO

[Boston Biotechs @BostonBioTechs]

Partnering with BBCR Consulting streamlines the clinical trial process by delivering tailored clinical and regulatory roadmaps. Our approach focuses on simplified programs and optimized protocols, designed to align seamlessly with each client’s unique… https://t.co/4r5gESDUbA

[Boston Biotechs @BostonBioTechs]

BBCR meets clients’ needs in the fast paced and ever-changing regulatory environment. As specialists in Orphan and Personalized Medicine, BBCR helps clients identify areas of need or economic interest and helps them to find homes for treatments for rare… https://t.co/cSe1lAbSHL

[Boston Biotechs @BostonBioTechs]

BBCR is highly experienced in developing innovative approaches to de-risk your product development during the early clinical development stage, including designing Proof of Concept (PoC) Trials and Proof of Mechanism (PoM) studies. Learn more at… https://t.co/zRzt09MI7v